Phillip M. Pontikos

FDA investigator

Appears on 5 documents from 2015 to 2019, most often at sites in France. Most often cites design controls (21 CFR 820.30).

5
Documents on file
7.4
Observations per 483
2015
First seen
2019
Most recent

What they cite most

From 37 observations

Activity by year

2015: 2, 2017: 1, 2018: 1, 2019: 1

Where

France 1 · Illinois 1 · Missouri 1 · New Jersey 1 · Washington 1

Is Phillip M. Pontikos coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

5 documents, newest first
FirmOpen
483 Pharmaceutical Innovations, IncMay 29, 2019 · Newark, New Jersey
483 Philips North America LLCDec 3, 2018 · Bothell, Washington
483 Meridian Medical Technologies, Inc. a Pfizer CompanyMar 24, 2017 · Brentwood, Missouri
483 Form 483 · FEI 3003110073Dec 10, 2015 · Dagneux, France
483 Hospira IncMay 27, 2015 · Lake Forest, Illinois

About this profile

What does Phillip M. Pontikos inspect?

Phillip M. Pontikos appears on 5 documents on file covering 5 sites, most often in France.

What do they cite most often?

21 CFR 820.30 (design controls), followed by 21 CFR 820.100 and 21 CFR 820.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Phillip M. Pontikos is dated May 29, 2019.